Supreme Court blocks thousands of Roundup lawsuits
The Supreme Court ruling blocks thousands of lawsuits against the maker of Roundup weedkiller, a decision that could reshape how plaintiffs pursue claims over the product’s alleged cancer risks.
High Court decision limits state‑court claims
In a 7‑2 vote, the justices held that Bayer AG cannot be sued in state courts for failing to warn users that Roundup might cause cancer. Federal regulations, which have not required a cancer warning on the label, preempt state‑law claims.
The company called the ruling “good for science, farmers, and industries that depend on regulatory clarity for innovation.” It expects pending failure‑to‑warn suits to be dismissed while it continues to negotiate a proposed $7.25 billion class‑action settlement intended to resolve many remaining claims.
Related: Justice Department files hundreds of health fraud charges
Background of the litigation
Scientific opinion on glyphosate, Roundup’s key ingredient, remains divided. The World Health Organization’s International Agency for Research on Cancer classified glyphosate as “probably carcinogenic” in 2015. The U.S. Environmental Protection Agency, however, has concluded that the chemical is unlikely to cause cancer when used as directed and approved a label that omits a cancer warning. EPA’s pesticide ingredient list reflects that stance.
Corporate response and settlement efforts
Bayer plans to proceed with a proposed $7.25 billion class‑action settlement intended to resolve many of the remaining claims. A federal judge recently ruled the settlement will be heard in a Missouri state court, where most of the lawsuits were filed. It also lobbied for state laws that would shield it from failure‑to‑warn liability; three states have agreed to such protections.
Reactions from advocates and industry
Environmental groups and attorneys for plaintiffs condemned the decision. “This Supreme Court ruling wrongly slams the courthouse door on Americans sickened by pesticides,” said Christopher Seeger, an attorney representing claimants in the proposed settlement. He added that the settlement could still provide compensation to some victims.
Related: NewLimit raises 435 million for life extension
Jay Feldman, executive director of Beyond Pesticides, called the ruling “a tragic setback for public and environmental health.” Patti Goldman, senior attorney at Earthjustice, argued that EPA approval does not guarantee safety and should not protect companies from warning‑label obligations.
Farmers expressed relief. Blake Hurst, a former Missouri Farm Bureau president, said the decision protects tools essential for soil care, crop protection, and affordable food for families.
Political context
The ruling aligns with the Trump administration’s approach to pesticide regulation but creates tension with the “Make America Healthy Again” movement, which advocates stricter controls on chemicals like glyphosate.
Related: Readers weigh in on health research topics
Legal analysts note the decision may not bar all claims against the company. Ashley Keller, an attorney for Durnell, said lawsuits challenging the product’s design could still proceed, suggesting the court’s focus was narrowly on warning‑label issues.
In the broader picture, the Supreme Court’s interpretation of federal preemption could influence future litigation involving other chemicals regulated at the federal level. The shift may prompt states to reconsider how they structure consumer‑protection statutes.
